Source
The a16z Show — What Happens When Everyone Has a Health Expert in Their Pocket? | OpenAI’s Karan Singhal (October 20, 2026) ·
at 10:35 ▸ ·
at 37:54 ▸
When this applies
when introducing AI assistance into an expert workflow where the goal is catching errors/blind spots, not replacing the expert's decision
The takeaway
Deploy AI as a non-intrusive safety net that flags deviations for expert review, rather than as a replacement decision-maker — and mine its aggregate flags for systemic insight.
Why it works
Positioning AI as a background safety net that proactively flags anomalies (rather than as a decision-maker or intermediary) lets experts retain control while catching errors they'd otherwise miss due to volume or attention limits; aggregated flags across many cases also reveal systemic patterns (e.g., overuse) invisible at the individual-case level.
One level up
Augmentation that preserves human final authority, while surfacing what busy experts miss, creates both safety value and emergent macro-level insight.
Where it stops holding
This stops working when the expert ignores or distrusts the flags, or when the AI's flags are too frequent/low-precision to be a credible safety net rather than noise.
Detail
situation: Clinicians can miss medication interactions or overuse patterns (e.g., antibiotics) due to volume and limited per-case attention.
decision: Deployed an AI co-pilot that proactively suggested flags (e.g., medication interactions) for clinician review without interfering or acting as a middleman.
outcome: Clinicians were found to be prone to antibiotic overuse; the model flagged this pattern, surfacing a systemic resistance-related issue beyond the local case.
lesson: A well-positioned safety net both catches individual errors and reveals system-level patterns worth addressing.
In their words
As an example, you know, in that context, the clinicians were a little bit prone to overuse of antibiotics. And a very common pattern that the models flagged is just kind of like avoiding this overuse of antibiotics and thinking less about the local case and more about the kind of global issue of resistance to antibiotics.